Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Other financing activities: 2009-2023

Historic Other financing activities for Cross Country Healthcare (CCRN) over the last 14 years, with FY2023 value amounting to -$508000.0.

  • Cross Country Healthcare's Other financing activities fell 84776.12% to -$501000.0 in Q2 2023 from the same period last year, while for Mar 2024 it was -$501000.0, marking a year-over-year decrease of 46304.35%. This contributed to the annual value of -$508000.0 for FY2023, which is 11569.35% down from last year.
  • According to the latest figures from FY2023, Cross Country Healthcare's Other financing activities is -$508000.0, which was down 11569.35% from $3.2 million recorded in FY2022.
  • In the past 5 years, Cross Country Healthcare's Other financing activities ranged from a high of $6.1 million in FY2021 and a low of -$508000.0 during FY2023
  • Moreover, its 5-year median value for Other financing activities was $2.1 million (2019), whereas its average is $2.2 million.
  • As far as peak fluctuations go, Cross Country Healthcare's Other financing activities surged by 742839.51% in 2021, and later plummeted by 11569.35% in 2023.
  • Annual analysis of 5 years shows Cross Country Healthcare's Other financing activities stood at $2.1 million in 2019, then plummeted by 96.06% to $81000.0 in 2020, then soared by 7428.4% to $6.1 million in 2021, then tumbled by 46.92% to $3.2 million in 2022, then crashed by 115.69% to -$508000.0 in 2023.
  • Its Other financing activities was -$508000.0 in FY2023, compared to $3.2 million in FY2022 and $6.1 million in FY2021.